RENB - Renovaro Inc. Company Long-Term Liabilities

Public company logo of renovarobio.com (RENB)

Renovaro Inc. (RENB) operates within a stable US legal framework, where the humanitarian status of medicine eliminates geopolitical threats. The price action for RENB shares shown below is accompanied by risks associated with a high burn rate and uncertainty regarding clinical trial outcomes, while long-term debt stands at 0.00. The business relies on AI platforms for early oncology detection, creating a protected biopharmaceutical environment.

Renovaro Inc. (RENB) Company Long-Term Debt: for the period 02/21/2024 - 10/01/2025

Renovaro (RENB) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price Renovaro Biosciences|RENB - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Renovaro|RENB - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share Renovaro|RENB - Company Book Value|Market Value to Book Value renovarobio.com|RENB - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Renovaro Inc.|RENB - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Renovaro Biosciences|RENB - Company Total Debt|Debts to Book Capitalization Renovaro|RENB - Company Long-Term Debt|Company Short-Term Loans and Borrowings Renovaro|Immediate Liquidity renovarobio.com
- earnings and market multiples details:
RENB - Company Net Income
Fundamental company valuation:RENB (Renovaro Inc.)
Brand item of Enochian BioSciences

Long-term debt reflects the aggregate of obligations with maturities exceeding one year, serving as an indicator of financial stability and management discipline in the use of borrowed capital. By analyzing the volume of an organization's long-term financial debt, an investor can assess loan servicing risks, which for Renovaro Inc. (RENB) are minimized through the implementation of an AI platform that reduces laboratory capital expenditures and optimizes the cash cycle.

Competitors of Renovaro Inc. (RENB)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt UroGen Pharma Ltd.|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DCTH (Delcath)|YMAB - Company Long-Term Liabilities|AURA: Company Long-Term Liabilities|CADL - Company Long-Term Debts|Accuray (ARAY) - Company Long-Term Debt|SELLAS Life Sciences Group - Company Long-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Long-Term Debts|Long-Term Debt Citius Oncology Inc CTOR|Company Long-Term Debt TuHURA Biosciences, Inc. (HURA)|TARA (protaratx.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts FATE (Fate Therapeutics)|Aadi Bioscience, Inc. (WHWK) - Long-Term Debt|TCRX - Company Long-Term Debt|CSBR (Champions Oncology) - Company Long-Term Indebtedness|xbiotech.com (XBIT) - Company Long-Term Debt|Long-Term Debt CEL-SCI (CVM)|Company Long-Term Liabilities OSTX|Company Long-Term Debt RADX|Company Long-Term Debts ARTV|Company Long-Term Debts adlainortye.com (ANL)|Company Long-Term Debt Veru Inc. VERU|Company Long-Term Loans and Borrowings TPST|XLO - Company Long-Term Debt|Long-Term Debt Mural Oncology plc|KAPA (kairospharma.com) - Company Long-Term Liabilities|OnKure Therapeutics - Company Long-Term Loans and Borrowings|GDTC (CytoMed Therapeutics Ltd) - Company Long-Term Debts|Curis Corp (CRIS) - Long-Term Debt Volume|Company Long-Term Debt Apollomics, Inc. (APLM)|Tharimmune Inc - Company Long-Term Indebtedness|Company Long-Term Debts ADVB (Advanced Biomed)|GNPX - Company Long-Term Liabilities|CLDI: Company Long-Term Liabilities|Long-Term Debt Volume Sunshine Biopharma Inc. SBFM|xeneticbio.com (XBIO) - Company Long-Term Debt|Salarius Pharmaceuticals Inc - Company Long-Term Loans and Borrowings|PPBT (Purple Biotech Corp) - Company Long-Term Debts|Long-Term Debt AON AONC|Company Long-Term Debt BeiGene, Ltd. (BGNE)|checkpointtx.com - Company Long-Term Indebtedness|Company Long-Term Debts ELEV (Elevation Oncology, Inc.)|iCAD Inc. - Company Long-Term Debt|Ikena - Company Long-Term Debts|Notable Labs Corp (NTBL) - Company Long-Term Liabilities|VIRX: Company Long-Term Debts|morphosys.com (MOR) - Company Long-Term Debts|Company Long-Term Debt NAYA Biosciences Inc.|Company Long-Term Indebtedness AAPGV (Ascentage Pharma Group International)